Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

Sharmilee Gnanapavan, Harald Hegen, Michael Khalil, Bernhard Hemmer, Diego Franciotta, Steve Hughes, Rogier Hintzen, Andreas Jeromin, Eva Havrdova, Hayrettin Tumani, Antonio Bertolotto, Manuel Comabella, Jette Frederiksen, José C. Álvarez-Cermeño, Luisa Villar, Daniela Galimberti, Kjell Morten Myhr, Irena Dujmovic, Franz Fazekas, Carolina IoneteTil Menge, Jens Kuhle, Geoffrey Keir, Florian Deisenhammer, Charlotte Teunissen, Gavin Giovannoni

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: The aim of these guidelines is to make the process of reporting body fluid biomarker studies in neurologic disorders more uniform and transparent, in line with existing standards for reporting research in other biomedical areas. Although biomarkers have been around for decades, there are concerns over the high attrition rate of promising candidate biomarkers at later phases of development. Methods: BioMS-eu consortium, a collaborative network working toward improving the quality of biomarker research in neurologic disorders, discussed the merits of standardizing the reporting of body fluid biomarker research. A checklist of items integrating the results of other published guidances, literature, conferences, regulatory opinion, and personal expertise was created to ultimately form a structured summary guidance incorporating the key features. Results: The summary guidance is comprised of a 10-point uniform reporting format ranging from introduction, materials and methods, through to results and discussion. Each item is discussed in detail in the guidance report. Conclusions: To enhance the future development of body fluid biomarkers, it will be important to standardize the reporting of studies. This guideline by the BioMS-eu consortium is aimed at setting a standard for the reporting of future body fluid biomarker research studies in neurologic disorders. We anticipate that following these guidelines will help to accelerate the selection of biomarkers for clinical development.

Original languageEnglish
Pages (from-to)1210-1216
Number of pages7
JournalNeurology
Volume83
Issue number13
DOIs
Publication statusPublished - Sep 1 2014

Fingerprint

Body Fluids
Nervous System Diseases
Biomarkers
Guidelines
Research
Checklist

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

Gnanapavan, S., Hegen, H., Khalil, M., Hemmer, B., Franciotta, D., Hughes, S., ... Giovannoni, G. (2014). Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology, 83(13), 1210-1216. https://doi.org/10.1212/WNL.0000000000000809

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. / Gnanapavan, Sharmilee; Hegen, Harald; Khalil, Michael; Hemmer, Bernhard; Franciotta, Diego; Hughes, Steve; Hintzen, Rogier; Jeromin, Andreas; Havrdova, Eva; Tumani, Hayrettin; Bertolotto, Antonio; Comabella, Manuel; Frederiksen, Jette; Álvarez-Cermeño, José C.; Villar, Luisa; Galimberti, Daniela; Myhr, Kjell Morten; Dujmovic, Irena; Fazekas, Franz; Ionete, Carolina; Menge, Til; Kuhle, Jens; Keir, Geoffrey; Deisenhammer, Florian; Teunissen, Charlotte; Giovannoni, Gavin.

In: Neurology, Vol. 83, No. 13, 01.09.2014, p. 1210-1216.

Research output: Contribution to journalArticle

Gnanapavan, S, Hegen, H, Khalil, M, Hemmer, B, Franciotta, D, Hughes, S, Hintzen, R, Jeromin, A, Havrdova, E, Tumani, H, Bertolotto, A, Comabella, M, Frederiksen, J, Álvarez-Cermeño, JC, Villar, L, Galimberti, D, Myhr, KM, Dujmovic, I, Fazekas, F, Ionete, C, Menge, T, Kuhle, J, Keir, G, Deisenhammer, F, Teunissen, C & Giovannoni, G 2014, 'Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders', Neurology, vol. 83, no. 13, pp. 1210-1216. https://doi.org/10.1212/WNL.0000000000000809
Gnanapavan, Sharmilee ; Hegen, Harald ; Khalil, Michael ; Hemmer, Bernhard ; Franciotta, Diego ; Hughes, Steve ; Hintzen, Rogier ; Jeromin, Andreas ; Havrdova, Eva ; Tumani, Hayrettin ; Bertolotto, Antonio ; Comabella, Manuel ; Frederiksen, Jette ; Álvarez-Cermeño, José C. ; Villar, Luisa ; Galimberti, Daniela ; Myhr, Kjell Morten ; Dujmovic, Irena ; Fazekas, Franz ; Ionete, Carolina ; Menge, Til ; Kuhle, Jens ; Keir, Geoffrey ; Deisenhammer, Florian ; Teunissen, Charlotte ; Giovannoni, Gavin. / Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. In: Neurology. 2014 ; Vol. 83, No. 13. pp. 1210-1216.
@article{59d7f9b757b34e3984f6d973694ce590,
title = "Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders",
abstract = "Objective: The aim of these guidelines is to make the process of reporting body fluid biomarker studies in neurologic disorders more uniform and transparent, in line with existing standards for reporting research in other biomedical areas. Although biomarkers have been around for decades, there are concerns over the high attrition rate of promising candidate biomarkers at later phases of development. Methods: BioMS-eu consortium, a collaborative network working toward improving the quality of biomarker research in neurologic disorders, discussed the merits of standardizing the reporting of body fluid biomarker research. A checklist of items integrating the results of other published guidances, literature, conferences, regulatory opinion, and personal expertise was created to ultimately form a structured summary guidance incorporating the key features. Results: The summary guidance is comprised of a 10-point uniform reporting format ranging from introduction, materials and methods, through to results and discussion. Each item is discussed in detail in the guidance report. Conclusions: To enhance the future development of body fluid biomarkers, it will be important to standardize the reporting of studies. This guideline by the BioMS-eu consortium is aimed at setting a standard for the reporting of future body fluid biomarker research studies in neurologic disorders. We anticipate that following these guidelines will help to accelerate the selection of biomarkers for clinical development.",
author = "Sharmilee Gnanapavan and Harald Hegen and Michael Khalil and Bernhard Hemmer and Diego Franciotta and Steve Hughes and Rogier Hintzen and Andreas Jeromin and Eva Havrdova and Hayrettin Tumani and Antonio Bertolotto and Manuel Comabella and Jette Frederiksen and {\'A}lvarez-Cerme{\~n}o, {Jos{\'e} C.} and Luisa Villar and Daniela Galimberti and Myhr, {Kjell Morten} and Irena Dujmovic and Franz Fazekas and Carolina Ionete and Til Menge and Jens Kuhle and Geoffrey Keir and Florian Deisenhammer and Charlotte Teunissen and Gavin Giovannoni",
year = "2014",
month = "9",
day = "1",
doi = "10.1212/WNL.0000000000000809",
language = "English",
volume = "83",
pages = "1210--1216",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

AU - Gnanapavan, Sharmilee

AU - Hegen, Harald

AU - Khalil, Michael

AU - Hemmer, Bernhard

AU - Franciotta, Diego

AU - Hughes, Steve

AU - Hintzen, Rogier

AU - Jeromin, Andreas

AU - Havrdova, Eva

AU - Tumani, Hayrettin

AU - Bertolotto, Antonio

AU - Comabella, Manuel

AU - Frederiksen, Jette

AU - Álvarez-Cermeño, José C.

AU - Villar, Luisa

AU - Galimberti, Daniela

AU - Myhr, Kjell Morten

AU - Dujmovic, Irena

AU - Fazekas, Franz

AU - Ionete, Carolina

AU - Menge, Til

AU - Kuhle, Jens

AU - Keir, Geoffrey

AU - Deisenhammer, Florian

AU - Teunissen, Charlotte

AU - Giovannoni, Gavin

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Objective: The aim of these guidelines is to make the process of reporting body fluid biomarker studies in neurologic disorders more uniform and transparent, in line with existing standards for reporting research in other biomedical areas. Although biomarkers have been around for decades, there are concerns over the high attrition rate of promising candidate biomarkers at later phases of development. Methods: BioMS-eu consortium, a collaborative network working toward improving the quality of biomarker research in neurologic disorders, discussed the merits of standardizing the reporting of body fluid biomarker research. A checklist of items integrating the results of other published guidances, literature, conferences, regulatory opinion, and personal expertise was created to ultimately form a structured summary guidance incorporating the key features. Results: The summary guidance is comprised of a 10-point uniform reporting format ranging from introduction, materials and methods, through to results and discussion. Each item is discussed in detail in the guidance report. Conclusions: To enhance the future development of body fluid biomarkers, it will be important to standardize the reporting of studies. This guideline by the BioMS-eu consortium is aimed at setting a standard for the reporting of future body fluid biomarker research studies in neurologic disorders. We anticipate that following these guidelines will help to accelerate the selection of biomarkers for clinical development.

AB - Objective: The aim of these guidelines is to make the process of reporting body fluid biomarker studies in neurologic disorders more uniform and transparent, in line with existing standards for reporting research in other biomedical areas. Although biomarkers have been around for decades, there are concerns over the high attrition rate of promising candidate biomarkers at later phases of development. Methods: BioMS-eu consortium, a collaborative network working toward improving the quality of biomarker research in neurologic disorders, discussed the merits of standardizing the reporting of body fluid biomarker research. A checklist of items integrating the results of other published guidances, literature, conferences, regulatory opinion, and personal expertise was created to ultimately form a structured summary guidance incorporating the key features. Results: The summary guidance is comprised of a 10-point uniform reporting format ranging from introduction, materials and methods, through to results and discussion. Each item is discussed in detail in the guidance report. Conclusions: To enhance the future development of body fluid biomarkers, it will be important to standardize the reporting of studies. This guideline by the BioMS-eu consortium is aimed at setting a standard for the reporting of future body fluid biomarker research studies in neurologic disorders. We anticipate that following these guidelines will help to accelerate the selection of biomarkers for clinical development.

UR - http://www.scopus.com/inward/record.url?scp=84921743474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921743474&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000000809

DO - 10.1212/WNL.0000000000000809

M3 - Article

C2 - 25150289

AN - SCOPUS:84921743474

VL - 83

SP - 1210

EP - 1216

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 13

ER -